NCT00989014View on ClinicalTrials.gov

Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions
Erythematotelangiectatic Rosacea
Interventions
DRUG

CD07805/47

0.5% Topical Gel

DRUG

CD07805/47

0.18% Topical Gel

DRUG

CD07805/47

0.07% Topical Gel

DRUG

CD07805/47 placebo

Vehicle Topical Gel

Trial Locations (5)

19034

Philadephia Institute of Dermatology, Fort Washington

24501

The Education & Research Foundation, Lynchburg

71913

Burke Pharmaceutical Research, Hot Springs

77845

J&S Studies, College Station

78759

Derm Research, Inc, Austin

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY